{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:59:18Z","timestamp":1793350758486,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3332024130"],"award-info":[{"award-number":["3332024130"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L232074"],"award-info":[{"award-number":["L232074"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114680","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:12:59Z","timestamp":1770016379000},"page":"114680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Large and low-PEG lipid nanoparticles enable efficient dendritic cell targeting for potent mRNA Cancer vaccines"],"prefix":"10.1016","volume":"392","author":[{"given":"Xiaolan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114680_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114680_bb0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.114680_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114680_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114680_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114680_bb0035","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.114680_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114680_bb0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114680_bb0050","article-title":"Elucidation of lipid nanoparticle surface structure in mRNA vaccines","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114680_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"Alvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114680_bb0060","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1529\/biophysj.106.083766","article-title":"Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane \"fusogen\"","volume":"91","author":"Tenchov","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2026.114680_bb0065","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114680_bb0070","doi-asserted-by":"crossref","first-page":"18758","DOI":"10.1021\/acsnano.3c02251","article-title":"An ionizable lipid material with a vitamin E scaffold as an mRNA vaccine platform for efficient cytotoxic T cell responses","volume":"17","author":"Oyama","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114680_bb0075","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114680_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0085","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s12274-023-6111-2","article-title":"Natural long-chain saturated fatty acids doped LNPs enabling spleen selective mRNA translation and potent cancer immunotherapy","volume":"17","author":"Wang","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.114680_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020240","article-title":"Conjugation of mannans to enhance the potency of liposome nanoparticles for the delivery of RNA vaccines","volume":"13","author":"Goswami","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114680_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.jconrel.2026.114680_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41551-025-01343-6","article-title":"Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection","volume":"9","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114680_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114680_bb0110","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2024.04.003","article-title":"RNA aggregates harness the danger response for potent cancer immunotherapy","volume":"vol. 187","author":"Mendez-Gomez","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114680_bb0115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jconrel.2022.06.017","article-title":"On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device","volume":"348","author":"Okuda","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114680_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.omtn.2017.11.005","article-title":"Rapid, single-cell analysis and discovery of vectored mRNA transfection in vivo with a loxP-Flanked tdTomato reporter mouse","volume":"10","author":"Kauffman","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.114680_bb0125","doi-asserted-by":"crossref","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","article-title":"Spleen-targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo","volume":"18","author":"Luo","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114680_bb0130","article-title":"Highly efficient expression of interleukin-2 under the control of rabbit beta-globin intron II gene enhances protective immune responses of porcine reproductive and respiratory syndrome (PRRS) DNA vaccine in pigs","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114680_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.vaccine.2008.10.078","article-title":"Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6\/E7 fusion antigen","volume":"27","author":"Yan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.114680_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Ramos da Silva","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114680_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114680_bb0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0155","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1126\/science.1080106","article-title":"Activation of lysosomal function during dendritic cell maturation","volume":"299","author":"Trombetta","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114680_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2020.07.106","article-title":"Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy","volume":"159","author":"Ohno","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0165","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells","volume":"23","author":"Feltkamp","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0170","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","article-title":"Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","article-title":"In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens","volume":"17","author":"Jung","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114680_bb0180","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114680_bb0185","article-title":"Macropinocytosis in different cell types: similarities and differences","volume":"10","author":"Lin","year":"2020","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.jconrel.2026.114680_bb0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114680_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.114680_bb0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400194121","article-title":"Supramolecular assembly of polycation\/mRNA nanoparticles and in vivo monocyte programming","volume":"121","author":"Hu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114680_bb0205","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114680_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.114680_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201095","article-title":"Anionic lipid nanoparticles preferentially deliver mRNA to the hepatic reticuloendothelial system","volume":"34","author":"Pattipeiluhu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114680_bb0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11095-012-0874-6","article-title":"Effect of PEGylation on biodistribution and gene silencing of siRNA\/lipid nanoparticle complexes","volume":"30","author":"Bao","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114680_bb0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114680_bb0230","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114680_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114680_bb0240","doi-asserted-by":"crossref","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Yanez Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114680_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.114680_bb0250","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114680_bb0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/bc1003179","article-title":"A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver","volume":"22","author":"Cormode","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114680_bb0260","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0265","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114680_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115065","article-title":"In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy","volume":"165","author":"Escalona-Rayo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114680_bb0275","first-page":"273","article-title":"beta-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model","volume":"39","author":"Nelson","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114680_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.114680_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11101580","article-title":"The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice","volume":"11","author":"Zhang","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.114680_bb0290","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1039\/D3TB00649B","article-title":"Rational design and combinatorial chemistry of ionizable lipids for RNA delivery","volume":"11","author":"Xu","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114680_bb0295","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-60761-421-0_28","article-title":"Defining in vivo dendritic cell functions using CD11c-DTR transgenic mice","volume":"595","author":"Bar-On","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ads1328","article-title":"An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses","volume":"10","author":"Aunins","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.114680_bb0305","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ccell.2020.05.002","article-title":"Visualizing synaptic transfer of tumor antigens among dendritic cells","volume":"37","author":"Ruhland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114680_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-025-02191-1","article-title":"Intranasal prime-boost RNA vaccination elicits potent T cell response for lung cancer therapy","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:35:47Z","timestamp":1787128547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":62,"alternative-id":["S0168365926000817"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114680","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Large and low-PEG lipid nanoparticles enable efficient dendritic cell targeting for potent mRNA Cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114680"}}